Icon	Function
💬	A pop-up explanation appears when you mouse-over the text beside this icon. Also, an explanation window appears when you click this icon.
	The links beside this icon are links to external sites.
	Clicking this icon sorts the table by the item with this icon (Numerical or alphabetical order). Each click toggles between ascending and descending order.
	A text longer than 100 characters is fully displayed or collapsed.
	The contents of the displayed table are downloaded as a file named "table.csv".

DR info

Clinical trials : 4 / Drugs : 9 - (DrugBank : 5) / Drug target genes : 3 - Drug target pathways : 14

Drugs, Primary sponsors and Trial info (Enrollment year, Phase, Trial ID, Countries)

ALE.F02
   Alentis Therapeutics AG
      2023   Phase 2   NCT06047171   Czechia;Denmark;France;Germany;Italy;Spain;Sweden;Switzerland;Turkey;United Kingdom
Corticosteroids
   National Taiwan University Hospital
      2006   Phase 3   NCT00354198   Taiwan
Cyclophosphamid
   Alentis Therapeutics AG
      2023   Phase 2   NCT06047171   Czechia;Denmark;France;Germany;Italy;Spain;Sweden;Switzerland;Turkey;United Kingdom
Glucocorticoid
   Alentis Therapeutics AG
      2023   Phase 2   NCT06047171   Czechia;Denmark;France;Germany;Italy;Spain;Sweden;Switzerland;Turkey;United Kingdom
Immunosuppressive agents
   Alentis Therapeutics AG
      2023   Phase 2   NCT06047171   Czechia;Denmark;France;Germany;Italy;Spain;Sweden;Switzerland;Turkey;United Kingdom
Methylprednisolone pulse
   Peking University First Hospital
      2016   Phase 2/Phase 3   NCT02647255   China
Pentoxifylline
   National Taiwan University Hospital
      2006   Phase 3   NCT00354198   Taiwan
Pioglitazone
   Assistance Publique - Hôpitaux de Paris
      2023   Phase 3   NCT05946564   France
Rituximab
   Alentis Therapeutics AG
      2023   Phase 2   NCT06047171   Czechia;Denmark;France;Germany;Italy;Spain;Sweden;Switzerland;Turkey;United Kingdom